speb/financial-data huggingface dataset:
Financial ratios for SMIF.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 368538098.6486487
Buffett classification: The Gruesome
Stock price: 0.01108108108108108
Shares outstanding: 361356026
Book value: 368538098.6486487
P/B ratio: 0.010865132907359795
Market cap (USD): 4004215.4232432432
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -14435351.351351352
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNG.AX — annual report dated 2021-12-31
Capital expenditures: 39865.94202898551
Buffett classification: The Gruesome
Stock price: 0.1884057971014493
Shares outstanding: 300011816
Market cap (USD): 56523965.33333334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNG.AX — annual report dated 2022-12-31
Operating income: -1202077.027027027
Net income: -1152679.7297297297
Capital expenditures: 106942.56756756757
Depreciation & amortization: 47036.48648648649
Net tangible assets: 11048073.64864865
Owner earnings: -1212585.810810811
Return on net tangible assets (%): -10.975540617971252
Buffett classification: The Gruesome
Stock price: 0.11486486486486487
Shares outstanding: 300011816
Book value: 11048073.64864865
P/B ratio: 3.1191697121712973
Market cap (USD): 34460816.7027027
Debt to equity: 0.0050820893381865705
Current ratio: 1.474740453985571
Quick ratio: 1.474740453985571
Interest coverage ratio: -336.9458333333333
Free cash flow (dilution-adjusted): -6567203.378378378
Buyback yield (%): 0.4375572758813488
Retained earnings: -3900256.756756757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.86213694710573
Rule of 40 score: 0
Financial ratios for SNG.AX — annual report dated 2023-12-31
Operating income: -1412811.6438356165
Net income: -1354333.5616438356
Capital expenditures: 1327377.397260274
Depreciation & amortization: 45626.02739726027
Net tangible assets: 12857147.260273973
Owner earnings: -2636084.9315068494
Return on net tangible assets (%): -20.502875779076028
Buffett classification: The Gruesome
Stock price: 0.0410958904109589
Shares outstanding: 300011816
Book value: 12857147.260273974
P/B ratio: 0.9589415492209304
Market cap (USD): 12329252.712328766
Debt to equity: 0.002715082784027966
Current ratio: 2.6881320106145474
Quick ratio: 2.6881320106145474
Interest coverage ratio: -301.65326118748175
Free cash flow (dilution-adjusted): -2517926.0273972605
Buyback yield (%): 1.7241376475207455
Retained earnings: -5169103.424657535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.981326944832634
Rule of 40 score: 0
Financial ratios for SNG.AX — annual report dated 2024-12-31
Operating income: -1170421.7391304348
Net income: -5830598.1366459625
Capital expenditures: 995553.4161490683
Depreciation & amortization: 29245.34161490683
Net tangible assets: 8747166.459627328
Owner earnings: -6796906.211180124
Return on net tangible assets (%): -77.70409129117802
Buffett classification: The Gruesome
Stock price: 0.03726708074534161
Shares outstanding: 300011816
Book value: 8747166.45962733
P/B ratio: 1.2781927293864388
Market cap (USD): 11180564.571428569
Debt to equity: 0.0010705152575407203
Current ratio: 20.372871655458578
Quick ratio: 20.372871655458578
Interest coverage ratio: -414.5136383633964
Free cash flow (dilution-adjusted): -2057758.3850931677
Buyback yield (%): 0.3877625051052434
Retained earnings: -10098549.06832298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.380581523542883
Rule of 40 score: 0
Financial ratios for SNG.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 8747166.459627328
Buffett classification: The Gruesome
Stock price: 0.03726708074534161
Shares outstanding: 300011816
Book value: 8747166.45962733
P/B ratio: 1.2781927293864388
Market cap (USD): 11180564.571428569
Debt to equity: 0.0010705152575407203
Current ratio: 20.372871655458578
Quick ratio: 20.372871655458578
Buyback yield (%): 0
Retained earnings: -10098549.06832298
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOMICONVEY.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4378214427007781
Shares outstanding: 11779656
Market cap (USD): 5157385.984438877
Buyback yield (%): 0
Retained earnings: 4493023.869181063
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOMICONVEY.NS — annual report dated 2023-03-31
Total revenue: 11409123.020706456
Gross profit: 1811035.3227771013
Operating income: 978855.054811206
Net income: 422423.8733252132
Capital expenditures: 83909.86601705238
Operating cash flow: 1899695.4933008528
Depreciation & amortization: 123325.21315468941
Net tangible assets: 7896479.902557856
Owner earnings: 461839.22046285024
Return on net tangible assets (%): 5.84867214457482
Capex to operating income (%): 8.5722462794286
Buffett classification: The Great
Stock price: 0.438489646772229
P/E ratio: 12.227664023528732
Shares outstanding: 11779656
Book value: 8099817.295980511
P/B ratio: 0.6377004578981798
Market cap (USD): 5165257.198538369
Debt to equity: 0.2647117647501109
Current ratio: 2.193888513720916
Quick ratio: 1.2189667874025416
Effective tax rate (%): 18.867262433911943
Interest coverage ratio: 4.0302908726178535
COGS to revenue (%): 84.12642830224331
SG&A to revenue (%): 1.060117071941701
Free cash flow (dilution-adjusted): 1815785.6272838004
Buyback yield (%): 0
Retained earnings: 4441144.945188794
Inventory turnover: 2.4810396398098296
Receivables turnover: 3.2003532832450126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.452072129073079
FCF margin (%): 15.915207715687918
Rule of 40 score: 15.915207715687918
Financial ratios for SOMICONVEY.NS — annual report dated 2024-03-31
Total revenue: 12239009.47355798
Gross profit: 2847139.9448375106
Operating income: 988523.8038134068
Net income: 545940.7602830075
Capital expenditures: 106043.8901546948
Operating cash flow: 673510.0131910301
Depreciation & amortization: 140088.7396570332
Net tangible assets: 8353003.95730903
Owner earnings: 579985.609785346
Return on net tangible assets (%): 6.943437507626799
Capex to operating income (%): 10.72749990901702
Buffett classification: The Great
Stock price: 1.5966890595009597
P/E ratio: 34.45144460387024
Shares outstanding: 11779656
Book value: 8520218.251588918
P/B ratio: 2.2075077544377795
Market cap (USD): 18808447.859884836
Debt to equity: 0.21398984660120116
Current ratio: 2.119012327444785
Quick ratio: 1.4292029096356627
Effective tax rate (%): 25.354976225610752
Interest coverage ratio: 6.764010831213588
COGS to revenue (%): 76.73717018531056
SG&A to revenue (%): 4.860715786915876
Free cash flow (dilution-adjusted): 567466.1230363353
Buyback yield (%): 0
Retained earnings: 4918395.491066075
Inventory turnover: 2.994478940445967
Receivables turnover: 2.496235875360759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.365898856419578
FCF margin (%): 4.636536349304485
Revenue growth (%): 7.2738846916223165
Rule of 40 score: 11.910421040926803
Financial ratios for SOMICONVEY.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 8853977.544194935
Buffett classification: The Gruesome
Stock price: 1.893573817486861
Shares outstanding: 11779656
Book value: 8856868.131868131
P/B ratio: 2.5184577492289253
Market cap (USD): 22305648.180602007
Debt to equity: 0.19059281426627486
Current ratio: 2.3888824828858573
Quick ratio: 1.367656697577317
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOMICONVEY.NS — annual report dated 2025-03-31
Total revenue: 11835129.763853168
Gross profit: 3276233.341126958
Operating income: 1061760.5798456862
Net income: 641360.7668926817
Capital expenditures: 118599.4856207622
Operating cash flow: -965033.9022679448
Depreciation & amortization: 155272.38718728078
Net tangible assets: 8945195.230301613
Owner earnings: 678033.6684592003
Return on net tangible assets (%): 7.579864396501701
Capex to operating income (%): 11.170078063926537
Buffett classification: The Great
Stock price: 2.074571128486405
P/E ratio: 38.102945335274605
Shares outstanding: 11779656
Book value: 8947638.531681085
P/B ratio: 2.7311937283311645
Market cap (USD): 24437734.24110165
Debt to equity: 0.27979659803418166
Current ratio: 2.0355065774554646
Quick ratio: 1.1574305891191956
Effective tax rate (%): 28.11865361686517
Interest coverage ratio: 4.787969845537456
COGS to revenue (%): 72.31772353579744
SG&A to revenue (%): 5.929806781465798
Free cash flow (dilution-adjusted): -1083633.387888707
Buyback yield (%): 0
Retained earnings: 5436824.877250409
Inventory turnover: 1.9098708975606449
Receivables turnover: 2.663168832535382
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.609428866155964
FCF margin (%): -9.156075256549684
Revenue growth (%): -3.299937879592158
Rule of 40 score: -12.456013136141841
Financial ratios for SOMICONVEY.NS — quarterly report dated 2025-03-31
Total revenue: 2839747.486555997
Gross profit: 787058.6859948562
Operating income: 213689.5019873743
Net income: 105003.5071311667
Capital expenditures: 0
Depreciation & amortization: 46235.67921440262
Net tangible assets: 8945195.230301613
Owner earnings: 151239.18634556932
Return on net tangible assets (%): 1.6907309729054383
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.074571128486405
P/E ratio: 58.18313813693596
Shares outstanding: 11779656
Book value: 8947638.531681085
P/B ratio: 2.7311937283311645
Market cap (USD): 24437734.24110165
Debt to equity: 0.27979659803418166
Current ratio: 2.0355065774554646
Quick ratio: 1.1574305891191956
Effective tax rate (%): 35.8657622277758
Interest coverage ratio: 3.360110294117647
COGS to revenue (%): 72.28420168620735
Buyback yield (%): 0
Retained earnings: 5436824.877250409
Inventory turnover: 0.458046272359452
Receivables turnover: 0.6390066817488294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3365089266426438
Rule of 40 score: 0
Financial ratios for SOMICONVEY.NS — quarterly report dated 2025-06-30
Total revenue: 3070805.05499649
Gross profit: 821039.0826117483
Operating income: 219892.34729698105
Net income: 140861.22162415166
Capital expenditures: 0
Depreciation & amortization: 39527.26421717763
Owner earnings: 180388.4858413293
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9218347765036277
P/E ratio: 40.17882333942516
Shares outstanding: 11779656
Market cap (USD): 22638552.556049615
Effective tax rate (%): 26.051968794151975
Interest coverage ratio: 3.607602226914955
COGS to revenue (%): 73.26306724434232
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.136553321531991
Rule of 40 score: 8.136553321531991
Financial ratios for SOMICONVEY.NS — quarterly report dated 2025-09-30
Total revenue: 2223765.5016910937
Gross profit: 702074.4081172491
Operating income: 182514.0924464487
Net income: 96978.57948139797
Capital expenditures: 0
Depreciation & amortization: 39458.85005636978
Net tangible assets: 8842863.585118376
Owner earnings: 136437.42953776775
Return on net tangible assets (%): 1.5429100338874144
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4777903043968434
P/E ratio: 50.77497797889302
Shares outstanding: 11779656
Book value: 8861183.765501691
P/B ratio: 1.9645074390288901
Market cap (USD): 17407861.4259301
Debt to equity: 0.19261768960555326
Current ratio: 2.5181243764549386
Quick ratio: 1.2054617656839925
Effective tax rate (%): 31.643356643356647
Interest coverage ratio: 3.520878642888212
COGS to revenue (%): 68.42857722258273
Buyback yield (%): 0
Inventory turnover: 0.3352458446345365
Receivables turnover: 0.7549006850625742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9866387530157292
Revenue growth (%): -27.583631592867903
Rule of 40 score: -27.583631592867903
Financial ratios for SOMICONVEY.NS — quarterly report dated 2025-12-31
Total revenue: 4175604.3221566225
Gross profit: 1312933.0511306673
Operating income: 384215.2166648101
Net income: 264921.4659685864
Capital expenditures: 0
Depreciation & amortization: 40392.11317812187
Owner earnings: 305313.57914670825
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.375403809735992
P/E ratio: 26.65798418633996
Shares outstanding: 11779656
Market cap (USD): 16201783.739779437
Effective tax rate (%): 24.911593836827482
Interest coverage ratio: 8.812212570260604
COGS to revenue (%): 68.55705306740938
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 87.77179153922596
Rule of 40 score: 87.77179153922596
Financial ratios for SRH.AX — annual report dated 2021-06-30
Total revenue: 9962544.360902255
Gross profit: 4739458.646616541
Operating income: 636690.2255639097
Net income: 402385.71428571426
Capital expenditures: 890951.1278195488
Depreciation & amortization: 911362.4060150376
Net tangible assets: 5170880.45112782
Owner earnings: 422796.99248120305
Return on net tangible assets (%): 8.17649907935866
Capex to operating income (%): 139.93478964286643
Buffett classification: The Gruesome
Stock price: 0.09022556390977443
P/E ratio: 9.719426204236761
Shares outstanding: 43346454
Book value: 6220909.022556391
P/B ratio: 0.6286795452976979
Market cap (USD): 3910958.2556390977
Debt to equity: 0.6455303718033617
Current ratio: 1.4105437786902923
Quick ratio: 0.6788114902007385
Effective tax rate (%): 7.931502536656362
Interest coverage ratio: 12.725002254079884
COGS to revenue (%): 52.42722667096547
SG&A to revenue (%): 23.942044880282413
Free cash flow (dilution-adjusted): -958563.909774436
Buyback yield (%): 0.07922601158255453
Retained earnings: 2014895.4887218045
Inventory turnover: 2.6114230851066225
Receivables turnover: 8.770402651868169
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8608654838586585
FCF margin (%): -9.621677706513358
Rule of 40 score: -9.621677706513358
Financial ratios for SRH.AX — annual report dated 2022-06-30
Total revenue: 8516838.620689655
Gross profit: 4746836.551724138
Operating income: 157653.7931034483
Net income: 44337.24137931035
Capital expenditures: 434954.4827586207
Depreciation & amortization: 1079582.7586206896
Net tangible assets: 4912002.068965517
Owner earnings: 688965.5172413792
Return on net tangible assets (%): 14.02616504570157
Capex to operating income (%): 275.8921775343616
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
P/E ratio: 53.93949695904431
Shares outstanding: 43346454
Book value: 5750412.413793104
P/B ratio: 0.415888170179818
Market cap (USD): 2391528.4965517246
Debt to equity: 0.6105313226109839
Current ratio: 1.3010925225047543
Quick ratio: 0.5690143399877056
Effective tax rate (%): 0
Interest coverage ratio: 2.9624954642061065
COGS to revenue (%): 44.26527537820412
SG&A to revenue (%): 32.68958629298746
Free cash flow (dilution-adjusted): 122017.24137931035
Buyback yield (%): 0
Retained earnings: 1892482.7586206896
Inventory turnover: 2.149948026072309
Receivables turnover: 6.795485823175848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9215147653646878
FCF margin (%): 1.432658839899798
Revenue growth (%): -14.511410818768697
Rule of 40 score: -13.0787519788689
Financial ratios for SRH.AX — annual report dated 2023-06-30
Total revenue: 9700990.72847682
Gross profit: 4979817.218543046
Operating income: -82732.45033112583
Net income: 84498.67549668874
Capital expenditures: 449437.0860927152
Depreciation & amortization: 1134178.1456953643
Net tangible assets: 4856841.059602649
Owner earnings: 769239.735099338
Return on net tangible assets (%): 15.838272771525933
Buffett classification: The Gruesome
Stock price: 0.052980132450331126
P/E ratio: 27.177951141520303
Shares outstanding: 43346454
Book value: 5391186.092715231
P/B ratio: 0.4259732152958515
Market cap (USD): 2296500.8741721855
Debt to equity: 0.5824060881318307
Current ratio: 1.0705180223283832
Quick ratio: 0.5200371438594871
Interest coverage ratio: -1.1263219582563224
COGS to revenue (%): 48.66692116378364
SG&A to revenue (%): 29.643248016724723
Free cash flow (dilution-adjusted): 857369.536423841
Buyback yield (%): 0
Retained earnings: 1901783.4437086093
Inventory turnover: 3.3629018905252965
Receivables turnover: 9.774324051109282
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.118158488936697
FCF margin (%): 8.837958518062196
Revenue growth (%): 13.903657924321204
Rule of 40 score: 22.7416164423834
Financial ratios for SRT.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 556.1931818181818
Shares outstanding: 34238669
Market cap (USD): 19043314252.329544
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRT.DE — annual report dated 2022-12-31
Total revenue: 4441170212.765958
Gross profit: 2317127659.574468
Operating income: 1212021276.5957448
Net income: 971382978.7234043
Capital expenditures: 555957446.8085107
Operating cash flow: 781063829.7872341
Depreciation & amortization: 305425531.9148936
Net tangible assets: -1076808510.638298
Owner earnings: 720851063.8297874
Return on net tangible assets (%): -66.9432918395574
Capex to operating income (%): 45.87027121916966
Buffett classification: The Good
Stock price: 350.3191489361702
P/E ratio: 12.347819189245428
Shares outstanding: 34238669
Book value: 2828617021.276596
P/B ratio: 4.240397796720448
Market cap (USD): 11994461384.787235
Debt to equity: 0.9557335740343751
Current ratio: 1.1219985581988576
Quick ratio: 0.468141740143071
Effective tax rate (%): 22.72996530422273
Interest coverage ratio: 32.36647727272728
COGS to revenue (%): 47.826191103552354
R&D to revenue (%): 4.292524013701583
SG&A to revenue (%): 20.267324598174717
Free cash flow (dilution-adjusted): 225106382.9787234
Buyback yield (%): 0
Inventory turnover: 1.6933254176914596
Receivables turnover: 8.876674463108655
Capitalized R&D asset: 190638297.87234044
ROCI (R&D-adjusted, %): 23.5125273958956
FCF margin (%): 5.068627685821736
Rule of 40 score: 5.068627685821736
Financial ratios for SRT.DE — annual report dated 2023-12-31
Total revenue: 3773000000
Gross profit: 1741777777.7777777
Operating income: 604333333.3333334
Net income: 322888888.8888889
Capital expenditures: 621888888.8888888
Operating cash flow: 948444444.4444444
Depreciation & amortization: 379555555.5555555
Net tangible assets: -3819444444.444444
Owner earnings: 80555555.55555558
Return on net tangible assets (%): -2.10909090909091
Capex to operating income (%): 102.9049457620886
Buffett classification: The Gruesome
Stock price: 291.1666666666667
P/E ratio: 30.874890610633173
Shares outstanding: 34238669
Book value: 3064444444.4444456
P/B ratio: 3.2531701274292955
Market cap (USD): 9969159123.833334
Debt to equity: 1.925779550398839
Current ratio: 1.4713533834586467
Quick ratio: 0.6918045112781956
Effective tax rate (%): 24.851305921903286
Interest coverage ratio: 3.7536231884057973
COGS to revenue (%): 53.835733427570155
R&D to revenue (%): 5.029890744176458
SG&A to revenue (%): 24.98748417115764
Free cash flow (dilution-adjusted): 326555555.5555555
Buyback yield (%): 0
Inventory turnover: 1.763213734567901
Receivables turnover: 10.18811881188119
Capitalized R&D asset: 317505437.35224587
ROCI (R&D-adjusted, %): 6.902167384448517
Rosenberg metric: -3.018018353174604
FCF margin (%): 8.655063757104573
Revenue growth (%): -15.044913406951405
Rule of 40 score: -6.389849649846832
Financial ratios for SRT.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 221.4333333333333
Shares outstanding: 34238669
Market cap (USD): 7581582605.566666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRT.DE — annual report dated 2024-12-31
Total revenue: 3521562500
Gross profit: 1587916666.6666667
Operating income: 455416666.6666667
Net income: 143125000
Capital expenditures: 426979166.6666667
Operating cash flow: 1016875000
Depreciation & amortization: 433229166.6666667
Net tangible assets: -2817187500
Owner earnings: 149375000.00000006
Return on net tangible assets (%): -5.302273987798117
Capex to operating income (%): 93.75571820677035
Buffett classification: The Gruesome
Stock price: 178.05208333333334
P/E ratio: 42.594000670815134
Shares outstanding: 34238669
Book value: 4060208333.333334
P/B ratio: 1.5014663892888294
Market cap (USD): 6096266346.010417
Debt to equity: 1.1698393965826877
Current ratio: 1.4631731967326596
Quick ratio: 0.9173473625917209
Effective tax rate (%): 26.445396145610278
Interest coverage ratio: 2.3747963063552415
COGS to revenue (%): 54.9087467092614
R&D to revenue (%): 5.82127961664744
SG&A to revenue (%): 26.14843079835537
Free cash flow (dilution-adjusted): 589895833.3333334
Buyback yield (%): 0
Inventory turnover: 2.3542168674698796
Receivables turnover: 11.318044861064612
Capitalized R&D asset: 395061749.40898347
ROCI (R&D-adjusted, %): 4.942284744109135
Rosenberg metric: -0.8107435597189686
FCF margin (%): 16.750968734285802
Revenue growth (%): -6.664126689636894
Rule of 40 score: 10.086842044648908
Financial ratios for SRT.DE — quarterly report dated 2024-12-31
Total revenue: 944583333.3333334
Gross profit: 411041666.6666667
Operating income: 145833333.33333334
Net income: 46250000
Capital expenditures: 94479166.66666667
Operating cash flow: 378437500
Depreciation & amortization: 123958333.33333334
Net tangible assets: -2817187500
Owner earnings: 75729166.66666667
Return on net tangible assets (%): -2.6881124052505085
Capex to operating income (%): 64.78571428571428
Buffett classification: The Good
Stock price: 178.05208333333334
P/E ratio: 32.95279105951577
Shares outstanding: 34238669
Book value: 4060208333.333334
P/B ratio: 1.5014663892888294
Market cap (USD): 6096266346.010417
Debt to equity: 1.1698393965826877
Current ratio: 1.4631731967326596
Quick ratio: 0.9173473625917209
Effective tax rate (%): 24.333333333333336
COGS to revenue (%): 56.484340538156154
R&D to revenue (%): 6.550507278341421
SG&A to revenue (%): 24.073665637406265
Free cash flow (dilution-adjusted): 283958333.3333334
Buyback yield (%): 0
Inventory turnover: 0.649587824984147
Receivables turnover: 3.0358218948778037
Capitalized R&D asset: 61875000
ROCI (R&D-adjusted, %): 2.060152790841726
FCF margin (%): 30.06175562417292
Rule of 40 score: 30.06175562417292
Financial ratios for SRT.DE — quarterly report dated 2025-03-31
Total revenue: 959782608.6956521
Gross profit: 468478260.8695652
Operating income: 149456521.73913044
Net income: 78913043.47826086
Capital expenditures: 0
Operating cash flow: 151304347.82608694
Depreciation & amortization: 112500000
Net tangible assets: -2916304347.826087
Owner earnings: 191413043.47826087
Return on net tangible assets (%): -6.563548266865449
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 183.55434782608697
P/E ratio: 19.910068987706616
Shares outstanding: 34238669
Book value: 4171413043.47826
P/B ratio: 1.506601358634078
Market cap (USD): 6284656558.728261
Debt to equity: 1.2063736091930064
Current ratio: 1.4577426758471717
Quick ratio: 0.9258809234507897
Effective tax rate (%): 27.035175879396984
Interest coverage ratio: 1.4816810344827587
COGS to revenue (%): 51.18912797281994
R&D to revenue (%): 5.628539071347678
SG&A to revenue (%): 26.26274065685164
Free cash flow (dilution-adjusted): 68586956.52173913
Buyback yield (%): 0
Inventory turnover: 0.5736768625460084
Receivables turnover: 2.7379844961240307
Capitalized R&D asset: 95477989.13043478
ROCI (R&D-adjusted, %): 1.7394524631077946
Rosenberg metric: 0.9282681891377536
FCF margin (%): 7.146092865232164
Revenue growth (%): 1.6090984062445968
Rule of 40 score: 8.755191271476761
Financial ratios for SRT.DE — quarterly report dated 2025-06-30
Total revenue: 1040352941.1764706
Gross profit: 489647058.8235294
Operating income: 155176470.5882353
Net income: 60941176.47058824
Capital expenditures: 100470588.23529412
Operating cash flow: 176705882.3529412
Depreciation & amortization: 120588235.29411764
Net tangible assets: -3088823529.4117646
Owner earnings: 81058823.52941178
Return on net tangible assets (%): -2.6242620453247008
Capex to operating income (%): 64.74601971190296
Buffett classification: The Good
Stock price: 206.87058823529412
P/E ratio: 38.05917780032227
Shares outstanding: 34238669
Book value: 4463882352.941176
P/B ratio: 1.5867294512716443
Market cap (USD): 7082973596.42353
Debt to equity: 1.2269456816804154
Current ratio: 1.394376166269867
Quick ratio: 0.88128177079982
Effective tax rate (%): 26.939351198871652
Interest coverage ratio: 2.1587561374795414
COGS to revenue (%): 52.934524482641635
R&D to revenue (%): 4.704285875833993
SG&A to revenue (%): 25.466470654755174
Free cash flow (dilution-adjusted): 76235294.11764707
Buyback yield (%): 0
Inventory turnover: 0.5870328567845498
Receivables turnover: 2.8216336949585195
Capitalized R&D asset: 105554491.68797955
ROCI (R&D-adjusted, %): 1.480772740725888
Rosenberg metric: 0.39185702449994153
FCF margin (%): 7.327829921972182
Revenue growth (%): 8.394643927786301
Rule of 40 score: 15.722473849758483
Financial ratios for SRT.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 189.05882352941177
P/E ratio: 34.782244497905985
Shares outstanding: 34238669
Market cap (USD): 6473122480.3529415
Buyback yield (%): 0
Capitalized R&D asset: 50617762.1483376
Rule of 40 score: 0
Financial ratios for SRT.DE — quarterly report dated 2025-12-31
Total revenue: 1091294117.647059
Gross profit: 466117647.0588235
Operating income: 200235294.11764705
Net income: 109647058.8235294
Capital expenditures: 161058823.52941176
Operating cash flow: 383529411.7647059
Depreciation & amortization: 130000000
Net tangible assets: -3048470588.2352943
Owner earnings: 78588235.29411766
Return on net tangible assets (%): -2.5779561593084286
Capex to operating income (%): 80.43478260869566
Buffett classification: The Gruesome
Stock price: 223.72941176470587
P/E ratio: 30.70203612849982
Shares outstanding: 34238669
Book value: 4549764705.882353
P/B ratio: 1.6836469070747033
Market cap (USD): 7660197274.97647
Debt to equity: 1.10736172523466
Current ratio: 0.8977330486937073
Quick ratio: 0.4950696350513367
Effective tax rate (%): 46.022031823745415
COGS to revenue (%): 57.26606295817162
R&D to revenue (%): 4.549374730487279
SG&A to revenue (%): 23.803363518758083
Free cash flow (dilution-adjusted): 222470588.23529413
Buyback yield (%): 0
Inventory turnover: 0.6705377429941933
Receivables turnover: 4.128170894526035
Capitalized R&D asset: 65797647.05882353
ROCI (R&D-adjusted, %): 2.3632218118113606
FCF margin (%): 20.385942216472618
Rule of 40 score: 20.385942216472618
Financial ratios for SRT.DE — annual report dated 2025-12-31
Total revenue: 4162470588.2352943
Gross profit: 1925529411.764706
Operating income: 669647058.8235295
Net income: 271058823.5294118
Capital expenditures: 519882352.9411765
Operating cash flow: 984705882.3529412
Depreciation & amortization: 494235294.11764705
Net tangible assets: -3048470588.2352943
Owner earnings: 245411764.70588237
Return on net tangible assets (%): -8.050324174127816
Capex to operating income (%): 77.63527758257203
Buffett classification: The Gruesome
Stock price: 223.72941176470587
P/E ratio: 28.26027640507812
Shares outstanding: 34238669
Book value: 4549764705.882353
P/B ratio: 1.6836469070747033
Market cap (USD): 7660197274.97647
Debt to equity: 1.10736172523466
Current ratio: 0.8977330486937073
Quick ratio: 0.4950696350513367
Effective tax rate (%): 31.602373887240358
Interest coverage ratio: 3.2656339644291457
COGS to revenue (%): 53.73788191402164
R&D to revenue (%): 4.917893784799751
SG&A to revenue (%): 25.341284870410675
Free cash flow (dilution-adjusted): 464823529.41176474
Buyback yield (%): 0
Inventory turnover: 2.400025246149962
Receivables turnover: 15.745883400089006
Capitalized R&D asset: 404682549.01960784
ROCI (R&D-adjusted, %): 7.083788841431094
Rosenberg metric: 1.64689143950263
FCF margin (%): 11.167010542381504
Revenue growth (%): 18.19953751311511
Rule of 40 score: 29.366548055496615
Financial ratios for STE.V — annual report dated 2021-07-31
Capital expenditures: 80645.16129032258
Buffett classification: The Gruesome
Stock price: 2.4596774193548385
Shares outstanding: 60125752
Market cap (USD): 147889954.51612902
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STE.V — annual report dated 2022-07-31
Total revenue: 0
Operating income: -10976645.3125
Net income: -10060285.9375
Capital expenditures: 39062.5
Operating cash flow: -8706327.34375
Net tangible assets: 11211892.1875
Owner earnings: -10099348.4375
Return on net tangible assets (%): -90.07710980988239
Buffett classification: The Gruesome
Stock price: 0.6640625
Shares outstanding: 60125752
Book value: 11211892.1875
P/B ratio: 3.561152437053792
Market cap (USD): 39927257.1875
Debt to equity: 0
Current ratio: 0.2783171837937037
Quick ratio: 0.2783171837937037
Free cash flow (dilution-adjusted): -8706327.34375
Buyback yield (%): 0
Retained earnings: -28867702.34375
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -97.90180933721184
Rule of 40 score: 0
Financial ratios for STE.V — annual report dated 2023-07-31
Total revenue: 0
Operating income: -1293860.1503759397
Net income: -1295896.992481203
Capital expenditures: 0
Operating cash flow: -3174030.07518797
Net tangible assets: 13202096.240601502
Owner earnings: -1295896.992481203
Return on net tangible assets (%): -9.815842642442066
Buffett classification: The Gruesome
Stock price: 0.5413533834586466
Shares outstanding: 60125752
Book value: 13202096.240601502
P/B ratio: 2.465462960199759
Market cap (USD): 32549279.278195485
Debt to equity: 0
Current ratio: 2.099988087699609
Quick ratio: 2.099988087699609
Free cash flow (dilution-adjusted): -3174030.07518797
Buyback yield (%): 0
Retained earnings: -29078347.36842105
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.800414470520401
Rule of 40 score: 0
Financial ratios for STE.V — annual report dated 2024-07-31
Total revenue: 0
Operating income: -1244746.3768115942
Net income: -3047556.521739131
Capital expenditures: 0
Operating cash flow: -893034.0579710145
Net tangible assets: 10221400
Owner earnings: -3047556.521739131
Return on net tangible assets (%): -29.815451129386688
Buffett classification: The Gruesome
Stock price: 0.30434782608695654
Shares outstanding: 60125752
Book value: 10221400
P/B ratio: 1.7902774485925097
Market cap (USD): 18299141.91304348
Debt to equity: 0
Current ratio: 0.05319674982734361
Quick ratio: 0.05319674982734361
Interest coverage ratio: -0.69217195924859
Free cash flow (dilution-adjusted): -1323106.5217391304
Buyback yield (%): 0
Retained earnings: -31072340.57971015
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.177846252094568
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.26618705035971224
Shares outstanding: 60125752
Market cap (USD): 16004696.575539568
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -175755.86206896554
Net income: -170684.1379310345
Capital expenditures: 0
Operating cash flow: -3014.4827586206898
Net tangible assets: 9485379.310344828
Owner earnings: -170684.1379310345
Return on net tangible assets (%): -1.7994445171516236
Buffett classification: The Gruesome
Stock price: 0.25517241379310346
Shares outstanding: 60125752
Market cap (USD): 15342433.268965518
Current ratio: 0.02598717198237913
Quick ratio: 0.02598717198237913
Free cash flow (dilution-adjusted): -3014.4827586206898
Buyback yield (%): 0
Retained earnings: -29814870.34482759
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -49417.39130434783
Net income: -44681.159420289856
Capital expenditures: 0
Operating cash flow: -419234.0579710145
Net tangible assets: 10937347.101449275
Owner earnings: -44681.159420289856
Return on net tangible assets (%): -0.40851916836733915
Buffett classification: The Gruesome
Stock price: 0.28260869565217395
Shares outstanding: 60125752
Book value: 10937347.101449275
P/B ratio: 1.5535815212058617
Market cap (USD): 16992060.34782609
Debt to equity: 0
Current ratio: 0.3422486381243135
Quick ratio: 0.3422486381243135
Free cash flow (dilution-adjusted): -419234.0579710145
Buyback yield (%): 0
Retained earnings: -31371900.724637683
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.45182246522833386
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2025-07-31
Total revenue: 0
Operating income: -267705.7971014493
Net income: -401578.9855072464
Capital expenditures: 0
Operating cash flow: -170652.89855072464
Net tangible assets: 10534818.84057971
Owner earnings: -401578.9855072464
Return on net tangible assets (%): -3.811921131100801
Buffett classification: The Gruesome
Stock price: 0.2608695652173913
Shares outstanding: 60125752
Book value: 10534818.84057971
P/B ratio: 1.4888702900320192
Market cap (USD): 15684978.782608695
Debt to equity: 0
Current ratio: 0.2292030819160934
Quick ratio: 0.2292030819160934
Free cash flow (dilution-adjusted): -170652.89855072464
Buyback yield (%): 0
Retained earnings: -31773479.71014493
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.541152355370906
Rule of 40 score: 0
Financial ratios for STE.V — annual report dated 2025-07-31
Total revenue: 0
Operating income: -578688.4057971014
Net income: -701139.1304347827
Capital expenditures: 0
Operating cash flow: -607059.4202898551
Net tangible assets: 10534818.84057971
Owner earnings: -701139.1304347827
Return on net tangible assets (%): -6.655445537744058
Buffett classification: The Gruesome
Stock price: 0.2608695652173913
Shares outstanding: 60125752
Book value: 10534818.84057971
P/B ratio: 1.4888702900320192
Market cap (USD): 15684978.782608695
Debt to equity: 0
Current ratio: 0.2292030819160934
Quick ratio: 0.2292030819160934
Interest coverage ratio: -4.108184577395956
Free cash flow (dilution-adjusted): -607059.4202898551
Buyback yield (%): 0
Retained earnings: -31773479.71014493
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.49310258253342
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -143600.7142857143
Net income: -139941.42857142858
Capital expenditures: 0
Operating cash flow: -257300.7142857143
Net tangible assets: 10244380
Owner earnings: -139941.42857142858
Return on net tangible assets (%): -1.3660312148849278
Buffett classification: The Gruesome
Stock price: 0.27142857142857146
Shares outstanding: 60125752
Book value: 10244380
P/B ratio: 1.5930536519953937
Market cap (USD): 16319846.971428573
Debt to equity: 0
Current ratio: 0.11181237262626004
Quick ratio: 0.11181237262626004
Free cash flow (dilution-adjusted): -257300.7142857143
Buyback yield (%): 0
Retained earnings: -31459514.285714287
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.401751148295107
Rule of 40 score: 0
Financial ratios for STE.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -162642.96296296295
Net income: -161275.55555555553
Capital expenditures: 0
Operating cash flow: -144824.44444444444
Net tangible assets: 10832896.296296295
Owner earnings: -161275.55555555553
Return on net tangible assets (%): -1.4887574951741642
Buffett classification: The Gruesome
Stock price: 0.34074074074074073
Shares outstanding: 60125752
Book value: 10832896.296296297
P/B ratio: 1.8912110587709177
Market cap (USD): 20487293.274074074
Debt to equity: 0
Current ratio: 0.21625824184520986
Quick ratio: 0.21625824184520986
Free cash flow (dilution-adjusted): -144824.44444444444
Buyback yield (%): 0
Retained earnings: -32785957.037037034
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5013802266211078
Rule of 40 score: 0
Financial ratios for UTIAMC.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.000659369642621
Shares outstanding: 128534565
Market cap (USD): 1413964966.7901886
Buyback yield (%): 0
Retained earnings: 423154424.370302
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTIAMC.NS — annual report dated 2023-03-31
Total revenue: 137803897.68574908
Gross profit: 91331303.28867236
Operating income: 53261875.76126675
Net income: 53554202.192448236
Capital expenditures: 6322777.101096225
Operating cash flow: 48164433.61753959
Depreciation & amortization: 4864799.025578563
Net tangible assets: 470632155.90743
Owner earnings: 52096224.116930574
Return on net tangible assets (%): 11.069414501965635
Capex to operating income (%): 11.871112330772046
Buffett classification: The Great
Stock price: 6.776248477466505
P/E ratio: 16.2635631701351
Shares outstanding: 128534565
Book value: 471113276.49208283
P/B ratio: 1.8487743688066212
Market cap (USD): 870982150.3830695
Debt to equity: 0
Current ratio: 13.841111632270168
Quick ratio: 13.841111632270168
Effective tax rate (%): 24.92059697414706
Interest coverage ratio: 42.7866927592955
COGS to revenue (%): 33.72371549537287
SG&A to revenue (%): 5.4482618418377715
Free cash flow (dilution-adjusted): 32449451.887941536
Buyback yield (%): 0.00041953562287831757
Retained earnings: 411704019.4884288
Receivables turnover: 12.98485022380351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.910969107046169
FCF margin (%): 23.54755738617782
Rule of 40 score: 23.54755738617782
Financial ratios for UTIAMC.NS — annual report dated 2024-03-31
Total revenue: 141750809.4495743
Gross profit: 93999280.4892673
Operating income: 52501498.98069313
Net income: 96178198.82479914
Capital expenditures: 9647439.740976136
Operating cash flow: 38987888.23599952
Depreciation & amortization: 5067753.927329416
Net tangible assets: 525307590.83823
Owner earnings: 91598513.01115242
Return on net tangible assets (%): 17.437119624521177
Capex to operating income (%): 18.37555103812156
Buffett classification: The Great
Stock price: 8.682581573896353
P/E ratio: 11.603584381016962
Shares outstanding: 128534565
Book value: 596379661.8299556
P/B ratio: 1.8713110407778948
Market cap (USD): 1116011845.6777833
Debt to equity: 0
Current ratio: 14.465019123271553
Quick ratio: 14.465019123271553
Effective tax rate (%): 18.727453285233675
Interest coverage ratio: 36.88374052232519
COGS to revenue (%): 33.686953284943236
SG&A to revenue (%): 5.561477420773904
Free cash flow (dilution-adjusted): 19681016.90850222
Buyback yield (%): 0
Retained earnings: 461833553.18383497
Receivables turnover: 14.183585313174948
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.466526270191663
FCF margin (%): 13.88423599478876
Revenue growth (%): 2.8641510364429816
Rule of 40 score: 16.748387031231744
Financial ratios for UTIAMC.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 517197802.1978022
Buffett classification: The Gruesome
Stock price: 13.762900143334926
Shares outstanding: 128534565
Book value: 596436932.6325848
P/B ratio: 2.9659605002222946
Market cap (USD): 1769008383.0619924
Debt to equity: 0
Current ratio: 3.652525836525258
Quick ratio: 3.652525836525258
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTIAMC.NS — quarterly report dated 2024-12-31
Total revenue: 43756848.11749621
Gross profit: 30535027.392469984
Operating income: 20901037.41694836
Net income: 20234293.041146986
Capital expenditures: 0
Depreciation & amortization: 1317169.8333139059
Owner earnings: 21551462.87446089
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.54913160041963
P/E ratio: 23.105159858870042
Shares outstanding: 128534565
Market cap (USD): 1870066301.387691
Effective tax rate (%): 21.519960215199603
Interest coverage ratio: 56.034375
COGS to revenue (%): 30.216574762247262
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UTIAMC.NS — quarterly report dated 2025-03-31
Total revenue: 42103109.65630114
Gross profit: 28432312.36848258
Operating income: 17682955.34252981
Net income: 11923076.923076922
Capital expenditures: 0
Depreciation & amortization: 1380640.6359597847
Net tangible assets: 537149871.4051905
Owner earnings: 13303717.559036708
Return on net tangible assets (%): 2.4767235863305754
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.449060567160696
P/E ratio: 30.85612944445564
Shares outstanding: 128534565
Book value: 603265139.1162028
P/B ratio: 2.4393917769135163
Market cap (USD): 1471600019.6586535
Debt to equity: 0
Current ratio: 9.571549623980511
Quick ratio: 9.571549623980511
Effective tax rate (%): 33.772727272727266
Interest coverage ratio: 45.836363636363636
COGS to revenue (%): 32.469804248229906
Buyback yield (%): 0
Retained earnings: 468524666.82253915
Receivables turnover: 4.517686904164576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.814045297087726
Revenue growth (%): -3.779382044964564
Rule of 40 score: -3.779382044964564
Financial ratios for UTIAMC.NS — annual report dated 2025-03-31
Total revenue: 168963058.21837735
Gross profit: 119160626.6074351
Operating income: 76155015.19756839
Net income: 95038578.44283375
Capital expenditures: 5917699.321954641
Operating cash flow: 62701660.04208557
Depreciation & amortization: 5323825.111059153
Net tangible assets: 537149871.4051905
Owner earnings: 94444704.23193827
Return on net tangible assets (%): 17.582561080182295
Capex to operating income (%): 7.770596994304836
Buffett classification: The Great
Stock price: 11.449060567160696
P/E ratio: 15.48423854575886
Shares outstanding: 128534565
Book value: 603265139.1162028
P/B ratio: 2.4393917769135163
Market cap (USD): 1471600019.6586535
Debt to equity: 0
Current ratio: 9.571549623980511
Quick ratio: 9.571549623980511
Effective tax rate (%): 22.734919262096433
Interest coverage ratio: 48.361544172234595
COGS to revenue (%): 29.475337470854
SG&A to revenue (%): 4.6848081034518545
Free cash flow (dilution-adjusted): 53971241.52443301
Buyback yield (%): 0
Retained earnings: 468524666.82253915
Receivables turnover: 18.129829402910186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.119222053959126
FCF margin (%): 31.94262822508666
Revenue growth (%): 19.19724400479237
Rule of 40 score: 51.13987222987903
Financial ratios for UTIAMC.NS — quarterly report dated 2025-06-30
Total revenue: 44382167.095717296
Gross profit: 29178563.070442315
Operating income: 18731570.325298388
Net income: 29705125.204774164
Capital expenditures: 0
Depreciation & amortization: 1435759.4196115143
Owner earnings: 31140884.624385677
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.042358998361808
P/E ratio: 29.176458215878707
Shares outstanding: 128534565
Market cap (USD): 1804928505.4282706
Effective tax rate (%): 22.133611434881292
Interest coverage ratio: 47.36094674556213
COGS to revenue (%): 34.25611010045084
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.4130382720438135
Rule of 40 score: 5.4130382720438135
Financial ratios for UTIAMC.NS — quarterly report dated 2025-12-31
Total revenue: 43972373.84426869
Gross profit: 29074300.991422527
Operating income: 18630945.75025064
Net income: 15351453.715049572
Capital expenditures: 0
Depreciation & amortization: 1411384.649660243
Owner earnings: 16762838.364709815
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.092569900857747
P/E ratio: 20.129953647014727
Shares outstanding: 128534565
Market cap (USD): 1554313211.9388435
Effective tax rate (%): 22.69591069725697
Interest coverage ratio: 50.22522522522523
COGS to revenue (%): 33.880528955768355
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.9233286210761718
Rule of 40 score: -0.9233286210761718
Financial ratios for VTR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.98
Shares outstanding: 486169723
Market cap (USD): 21381744417.539997
Buyback yield (%): 0.00044898114075879014
Retained earnings: -4679889000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTR — annual report dated 2022-12-31
Total revenue: 4129193000
Gross profit: 1846275000
Operating income: 483846000
Net income: -40931000
Capital expenditures: 454069000
Operating cash flow: 1120163000
Depreciation & amortization: 1210755000
Net tangible assets: 9102160000
Owner earnings: 715755000
Capex to operating income (%): 93.84576910835266
Buffett classification: The Gruesome
Stock price: 40.23
Shares outstanding: 486169723
Book value: 10221677000
P/B ratio: 1.9134441399674436
Market cap (USD): 19558607956.289997
Debt to equity: 1.2216410281796226
Current ratio: 0.6116777101156471
Quick ratio: 0.6116777101156471
Interest coverage ratio: 1.0348385330558627
COGS to revenue (%): 55.287267996434174
SG&A to revenue (%): 3.5085306015001
Free cash flow (dilution-adjusted): 635379000
Buyback yield (%): 0
Retained earnings: -5449385000
Receivables turnover: 5.5133166610810616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1427236228585707
FCF margin (%): 15.387486126223695
Rule of 40 score: 15.387486126223695
Financial ratios for VTR — annual report dated 2023-12-31
Total revenue: 4497827000
Gross profit: 1936581000
Operating income: 415514000
Net income: -30297000
Capital expenditures: 643005000
Operating cash flow: 1119873000
Depreciation & amortization: 1414877000
Net tangible assets: 8437298000
Owner earnings: 741575000
Capex to operating income (%): 154.7492984592577
Buffett classification: The Gruesome
Stock price: 46.29
Shares outstanding: 486169723
Book value: 9544405000
P/B ratio: 2.357904602504818
Market cap (USD): 22504796477.67
Debt to equity: 1.4338903263220704
Current ratio: 0.7343487263463107
Quick ratio: 0.7343487263463107
Interest coverage ratio: 0.723750766400981
COGS to revenue (%): 56.944075439095364
SG&A to revenue (%): 3.3099538955144334
Free cash flow (dilution-adjusted): 445881000
Buyback yield (%): 0
Receivables turnover: 18.118426883011207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7649028921982242
FCF margin (%): 9.913253666715061
Revenue growth (%): 8.927507142436792
Rule of 40 score: 18.840760809151853
Financial ratios for VTR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.71
Shares outstanding: 486169723
Market cap (USD): 29515363883.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.58
Shares outstanding: 486169723
Market cap (USD): 27507482927.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTR — annual report dated 2024-12-31
Total revenue: 4924266000
Gross profit: 2097197000
Operating income: 681230000
Net income: 88351000
Capital expenditures: 603846000
Operating cash flow: 1329625000
Depreciation & amortization: 1283286000
Net tangible assets: 9714839000
Owner earnings: 767791000
Return on net tangible assets (%): 7.903280744024682
Capex to operating income (%): 88.64054724542372
Buffett classification: The Gruesome
Stock price: 56.58
P/E ratio: 311.34319846226975
Shares outstanding: 486169723
Book value: 10829596000
P/B ratio: 2.540028540985278
Market cap (USD): 27507482927.34
Debt to equity: 1.2687965460576738
Current ratio: 1.0908555811197955
Quick ratio: 1.0908555811197955
Effective tax rate (%): -74.68957608351788
Interest coverage ratio: 1.130043876019143
COGS to revenue (%): 57.41097251854388
SG&A to revenue (%): 3.309934922280803
Free cash flow (dilution-adjusted): 694788000
Buyback yield (%): 0
Receivables turnover: 13.107747101225524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7378280928659975
FCF margin (%): 14.109473371259798
Revenue growth (%): 9.481000492015367
Rule of 40 score: 23.590473863275164